Pharmacological characterization of A-13
✍
Arthur A. Hancock; Steven A. Buckner; Michael E. Brune; Sweta Katwala; Ivan Mili
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 445 KB
👁 1 views
New compounds selective for α 1A -adrenoceptors in the prostate may offer enhanced efficacy for benign prostatic hyperplasia (BPH), with fewer side effects than current treatment. A-131701 (3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b,hexahydro-[1H]-benz[e]isoindol-2-yl)ethyl]pyrido[3′,4′:4,5]thieno